Drugs / Live attenuated Poliomyelitis vaccine (Human Diploid Cell)
Live attenuated Poliomyelitis vaccine (Human Diploid Cell)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02231632 | Jan 2011 → Mar 2012 | poliomyelitis | Institute of Medical Biology, Chinese Academy of Medical Sciences | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live attenuated Poliomyelitis vaccine (Human Diploid Cell) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02231632 ↗ |
| Modality | Vaccine | “Live attenuated Poliomyelitis vaccine (Human Diploid Cell)” NCT02231632 ↗ |
| Route | Oral | “Poliomyelitis（Live）Vaccine(Human Diploid Cell),Oral” NCT02231632 ↗ |